COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series
Ines Colmegna, Valeria Valerio, Nathalie Amiable, Mariana Useche, Emmanouil Rampakakis, Louis Flamand, Emmanuelle Rollet-Labelle, Louis Bessette, Mary-Ann Fitzcharles, Elizabeth Hazel, Deirdre McCormack, Laëtitia Michou, Pantelis Panopalis, Marc-André Langlois, Sasha Bernatsky, Paul R Fortin
RMD Open Nov 2023, 9 (4) e003400; DOI: 10.1136/rmdopen-2023-003400